Medical Equipment

Global Self-Injections Market Set To Expand To $15.04 Billion By 2030 At 8.1% CAGR

April 15, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Self-Injections Market From 2026 To 2030?

The self-injections market has seen significant expansion in recent years. Its valuation is anticipated to rise from $10.22 billion in 2025 to $11.04 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. This historic growth can be ascribed to factors such as the increasing prevalence of chronic diseases, the wider availability of injectable biologics, a growing inclination towards home-based treatment, the broadening scope of specialty pharmaceuticals, and enhancements in the ergonomics of injection devices.

The self-injections market size is predicted to demonstrate robust expansion over the next few years. It is expected to reach $15.05 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.1%. This projected growth is driven by the rising demand for self-care therapies, the increasing embrace of digital health-enabled injectors, the broadening of biologics pipelines, a heightened focus on drug delivery methods that improve adherence, and the expanding utilization of connected medical devices. Significant trends for this period include the increased adoption of auto-injector devices, a surge in the need for wearable injection systems, the growing application of biologic self-administered therapies, the development of patient-centric drug delivery designs, and an enhanced emphasis on safety and dose accuracy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Self-Injections Market?

The increasing count of individuals with diabetes is anticipated to drive the expansion of the self-injections market in the future. Diabetes is defined as a medical state where the pancreas, an organ responsible for insulin production, generates insufficient insulin, resulting in elevated blood sugars and severe health issues such as cardiac problems, sight impairment, and renal disorders. Diabetic individuals can utilize self-injections to administer insulin and various other medications, assisting them in sustaining optimal blood sugar levels and preventing any surplus blood sugars at any moment, independently of a healthcare provider. For example, reports from Diabetes Care, a US-based international peer reviewed medical journal, indicate that in November 2025, approximately 634.8 million adults, comprising 12.0 percent of the worldwide adult populace, experienced impaired glucose tolerance in 2024. This figure is projected to climb to 846.5 million adults, or 12.9 percent of the world’s adult population, by 2050. Consequently, the rising population of diabetic patients is fueling the expansion of the self-injections market.

How Is Segmentation Applied In The Self-Injections Market Segment Analysis?

The self-injections market covered in this report is segmented –

1) By Type: Devices, Formulations

2) By Dosage: Single Dose, Multi Dose

3) By Application: Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Pain Management, Other Applications

4) By Distribution Channel: Chemist, Online Pharmacies

Subsegments:

1) By Devices: Pre-Filled Syringes, Auto-Injectors, Microneedle Devices, Wearable Injectors

2) By Formulations: Biologics, Small Molecules, Combination Products

Which Trends Are Shaping The Self-Injections Market?

Leading companies in the self-injections market are concentrating on advancing drug delivery methods, such as hands-free, hidden-needle subcutaneous delivery, to streamline patient self-administration of high-volume biologics. This hands-free, hidden-needle subcutaneous delivery involves a wearable injector that delivers medication discreetly without manual activation, while keeping the needle concealed to enhance comfort and safety. As an illustration, in November 2023, Enable Injections Inc., a US-based drug-delivery technology company, secured its first US Food and Drug Administration (FDA) approval for the enFuse large-volume wearable injector for use with EMPAVELI (pegcetacoplan). This compact, mechanical, body-worn system delivers up to 25 mL subcutaneously, allowing for self-administration or in-clinic administration and offering features like hands-free operation and reduced disruption to patients’ daily routines. The enFuse platform boosts convenience, facilitates home-based care, and elevates the overall patient experience for large-volume therapy delivery.

Who Are The Companies Participating In The Self-Injections Market Environment?

Major companies operating in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.

Get The Full Self-Injections Market Report:

https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report

Which Region Accounts For The Largest Portion Of The Self-Injections Market?

North America was the largest region in the self-injections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Self-Injections Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report

Browse Through More Reports Similar to the Global Self-Injections Market 2026, By The Business Research Company

Injection Pen Market Report 2026

https://www.thebusinessresearchcompany.com/report/injection-pen-global-market-report

Chemical Injection Pumps Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemical-injection-pumps-global-market-report

Chemical Injection Skids Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemical-injection-skids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795